ASCEND

Serial Number 90755378
645

Registration Progress

Application Filed
Jun 4, 2021
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Mar 15, 2026 81 days

Trademark Image

ASCEND

Basic Information

Serial Number
90755378
Filing Date
June 4, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
645
Status Date
Dec 15, 2025
Application
Pending
Classes
005

Rights Holder

Ascend Laboratories, LLC

16
Address
339 Jefferson Rd, Suite 101
Parsippany, NJ 07054

Ownership History

Ascend Laboratories, LLC

Original Applicant
16
Parsippany, NJ

Legal Representation

Attorney
Howard Shipley

USPTO Deadlines

Next Deadline
81 days remaining
Final Refusal E-Mailed
Due Date
March 15, 2026
Extension Available
Until June 15, 2026

Application History

27 events
Date Code Type Description Documents
Dec 15, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 15, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Dec 15, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 12, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Mar 12, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Dec 12, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 12, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 12, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 5, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 5, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 5, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 9, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 8, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 8, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 27, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 26, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 8, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, mycophenolate mofetil capsules, cephalexin capsules, metformin hydrochloride tablets, ibuprofen tablets, amlodipine besylate tablets, benzonatate capsules, temazepam capsules, quetiapine fumarate tablets
First Use Anywhere: Jan 1, 2008
First Use in Commerce: Jan 1, 2008

Additional Information

Design Mark
The mark consists of the word "ASCEND" with a stylized brush stroke on top of the letter 'A'.

Classification

International Classes
005